Skip to main content

CSD

ETF
—
—

Performance overview

CSD Price
Price Chart

Forward-looking statistics

Beta
1.18
Risk
22.33%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

—

Fund info

—

Investing methodPassively Managed
DiversifiedYes
Expense ratio0.62%
Asset classUnknown

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeNyse American
Type of shareN/A
Earnings per share (EPS)—
Dividend per share$1.80
Revenue per share—
Avg trading volume (30 day)$120K
Avg trading volume (10 day)$101K
Put-call ratioN/A

Macro factor sensitivity

Growth+1.2
Credit+3.8
Liquidity-0.0
Inflation-1.4
Commodities-0.2
Interest Rates-1.8

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend dayDecember 19, 2022

News

ETFs to Bet on the Successful Debut of Kenvue

Kenvue is the world's largest pure-play consumer health company by revenue, and makes well-known products, including Tylenol, Neutrogena, Listerine, Johnson???s', Band-Aid, Aveeno, Zyrtec and Nicorette.

Zacks Investment Research (May 5, 2023)
3 ETFs With Powerful Penn National Exposure

Previously on the brink with rampant speculation about its ability to survive in a zero revenue environment, Penn National Gaming (NASDAQ: PENN) is easily one of this year's best redemption stories, returning more than 1,700% from its March lows.

Benzinga (September 21, 2020)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage